Does BROLUCIZUMAB-DBLL Cause Blindness? 191 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 191 reports of Blindness have been filed in association with BROLUCIZUMAB-DBLL. This represents 6.8% of all adverse event reports for BROLUCIZUMAB-DBLL.
191
Reports of Blindness with BROLUCIZUMAB-DBLL
6.8%
of all BROLUCIZUMAB-DBLL reports
3
Deaths
20
Hospitalizations
How Dangerous Is Blindness From BROLUCIZUMAB-DBLL?
Of the 191 reports, 3 (1.6%) resulted in death, 20 (10.5%) required hospitalization.
Is Blindness Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BROLUCIZUMAB-DBLL. However, 191 reports have been filed with the FAERS database.
What Other Side Effects Does BROLUCIZUMAB-DBLL Cause?
Vitreous floaters (479)
Visual impairment (446)
Vision blurred (416)
Eye inflammation (387)
Visual acuity reduced (365)
Retinal vasculitis (323)
Uveitis (305)
Vitritis (284)
Eye pain (234)
Vitreous opacities (205)
What Other Drugs Cause Blindness?
ADALIMUMAB (1,599)
AFLIBERCEPT (1,337)
BEVACIZUMAB (847)
INSULIN GLARGINE (837)
APIXABAN (789)
INSULIN LISPRO (760)
RANIBIZUMAB (760)
ETANERCEPT (669)
PREGABALIN (646)
ESOMEPRAZOLE (617)
Which BROLUCIZUMAB-DBLL Alternatives Have Lower Blindness Risk?
BROLUCIZUMAB-DBLL vs BROMAZEPAM
BROLUCIZUMAB-DBLL vs BROMFENAC
BROLUCIZUMAB-DBLL vs BROMHEXINE
BROLUCIZUMAB-DBLL vs BROMOCRIPTINE
BROLUCIZUMAB-DBLL vs BROTIZOLAM